These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 20443735)

  • 1. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8(+) T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis.
    Wada T; Kurokawa T; Toma T; Shibata F; Tone Y; Hashida Y; Kaya H; Yoshida T; Yachie A
    Eur J Haematol; 2007 Jul; 79(1):72-5. PubMed ID: 17532761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of CD5 expression on activated CD8+ T cells in familial hemophagocytic lymphohistiocytosis with perforin gene mutations.
    Wada T; Sakakibara Y; Nishimura R; Toma T; Ueno Y; Horita S; Tanaka T; Nishi M; Kato K; Yasumi T; Ohara O; Yachie A
    Hum Immunol; 2013 Dec; 74(12):1579-85. PubMed ID: 24051121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.
    Lin MT; Chang HM; Huang CJ; Chen WL; Lin CY; Lin CY; Chuang SS
    J Clin Pathol; 2007 Jan; 60(1):101-3. PubMed ID: 17213357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring of Epstein-Barr virus-infected cells by flow cytometer permits early diagnosis and evaluation of disease progression in EBV-associated hemophagocytic lymphohistiocytosis].
    Fukuda M; Nishimura R; Araki R; Kuroda R; Mase S; Nakagawa Y; Tone Y; Maeba H; Wada T; Kasahara Y; Yachie A
    Rinsho Ketsueki; 2012 Mar; 53(3):337-41. PubMed ID: 22499051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of type II latency in T lymphocytes of Epstein-Barr Virus-associated hemophagocytic lymphohistiocytosis.
    Ito Y; Kawamura Y; Iwata S; Kawada J; Yoshikawa T; Kimura H
    Pediatr Blood Cancer; 2013 Feb; 60(2):326-8. PubMed ID: 22961815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
    Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
    Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N; Kimura H; Hara S; Hoshino Y; Kojima S; Morishima T; Tsurumi T; Kuzushima K
    J Infect Dis; 2004 Sep; 190(5):985-8. PubMed ID: 15295706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic difficulties of the hemophagocytic lymphohistiocytosis (HLH) associated with the Epstein-Barr virus.
    Gonzalo DH; Rodriguez G; Marcilla D
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):206-7. PubMed ID: 17356405
    [No Abstract]   [Full Text] [Related]  

  • 10. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T; Ouyang Q; Flad T; Koetter I; Bühring HJ; Kalbacher H; Pawelec G; Müller CA
    J Rheumatol; 2005 Feb; 32(2):239-51. PubMed ID: 15693083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
    Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
    Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two young adult cases of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis with monoclonal proliferation of virus-infected cells within a short period after primary infection].
    Idutsu K; Abe Y; Matsushima T; Sada E; Ohtsuka R; Kiyasu J; Shiratsuchi M; Kotoh K; Nishimura J; Ohga S; Takayanagi R
    Rinsho Ketsueki; 2008 Nov; 49(11):1541-7. PubMed ID: 19047785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis.
    Matsuda K; Nakazawa Y; Yanagisawa R; Honda T; Ishii E; Koike K
    Clin Chim Acta; 2011 Aug; 412(17-18):1554-8. PubMed ID: 21570959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow Cytometric Analysis of T Cells in Hemophagocytic Lymphohistiocytosis.
    Park MS; Yoo IY; Kim HJ; Kim SH; Kim SJ; Cho D
    Ann Lab Med; 2019 Sep; 39(5):430-437. PubMed ID: 31037861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy.
    Chikagawa Y; Hikishima K; Mizumaki H; Sugimori C; Nakagishi Y; Yachie A; Nakao S
    Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kawada J; Kimura H; Shibata Y; Hara S; Hoshino Y; Kojima S; Nishikawa K; Morishima T
    J Med Virol; 2006 Mar; 78(3):400-7. PubMed ID: 16419109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological findings and treatment of EBV-associated hemophagocytic lymphohistiocytosis: a case report.
    Przybylski M; Dzieciatkowski T; Zduńczyk D; Jedrzejczak WW; Luczak M
    Arch Immunol Ther Exp (Warsz); 2010 Jun; 58(3):247-52. PubMed ID: 20383798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
    Abe Y; Shiratsuchi M; Nagasawa E; Ohtsuka R; Kiyasu J; Sada E; Idutsu K; Kotoh K; Nishimura J; Ohga S; Takayanagi R
    Rinsho Ketsueki; 2010 Jan; 51(1):74-9. PubMed ID: 20134144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.